Abstract:The objective of this study was to explore the application value of microbubble contrast materials in the diagnosis of prostate cancer. Firstly, ordinary nano-microbubbles and biotinylated nano-microbubbles were prepared by rotary evaporation method and mechanical vibration method. Then, the biotinylated anti-six-transmembrane prostate epithelial antigen-1 (STQWK-1) antibody was connected with the previously prepared nano-microbubbles with the help of biotin-avidin method, so as to generate a nano-microbubble contrast agent targeting prostate PC3 cells. While the contrast agent was characterized based on the immunofluorescence method, a microscope was applied to observe the in vitro targeting performance of targeted nano-microbubbles on PC3 cells. A prostate PC3 cell nude mouse transplanted tumor model was established, so that the contrast-enhanced ultrasound (CEUS) effect of different contrast agents on transplanted tumor was compared, which were applied in CEUS examination of prostate cancer patients. The results showed that the targeted nano-microbubbles could display circular green fluorescence under the microscope, and the blank nano-microbubbles had no display under the microscope. Both ultrasonic microbubbles were circular and evenly distributed. The in vitro targeting experiments indicated that targeted nano-bubbles could accumulate on the surface of prostate cancer PC3 cells, and tumor transplantation model proved that the targeted contrast agent carrying STQWK-1 antibody had a strong development and enhancement effect. In the diagnosis of prostate cancer patients, the sensitivity (83.3% vs. 52%), specificity (66.7% vs. 36.3%), accuracy (75% vs. 47.2%), and other indicators of the diagnosis of targeted nano-bubbles prepared showed marked advantages compared with routine trans-rectal US (TRUS) diagnosis. The contrast agent prepared in this study could be specifically targeted to prostate PC3 cells in vitro , which had the effect of development and enhancement and had a good diagnostic performance in the diagnosis of prostate cancer.

Preparation of Targeted Nano-Microbubble Contrast Agent and Its Application in the Diagnosis of Prostate Cancer